Song Gao
Articles
-
Dec 12, 2024 |
mdpi.com | Song Gao
1. IntroductionDiclofenac is a widely prescribed non-steroidal anti-inflammatory drug (NSAID) that has promising anti-inflammatory, analgesic, and antipyretic properties. It is clinical proven effective in treating various acute and chronic pain and inflammation conditions [1]. Pharmacological studies have demonstrated that diclofenac exerts its efficacy by inhibiting cyclooxygenases, thereby reducing the production of prostaglandin E2 (PGE2), a pro-inflammatory prostaglandin [2].
-
Nov 12, 2024 |
opg.optica.org | Song Gao |Shijing Guo |Jiaran Xiong |Dong Wang
A multifunctional terahertz functional device based on vanadium dioxide (${{\rm VO}_2}$) and graphene is proposed, which can realize ultra-wideband absorption and polarization conversion. When the ${{\rm VO}_2}$ is in the insulating state, the device can achieve the polarization conversion function to convert the incident wave into the corresponding cross-polarized wave.
-
Aug 31, 2024 |
arxiv.org | Song Gao
-
Jul 23, 2024 |
chemistry-europe.onlinelibrary.wiley.com | Song Gao |Kang Wang |Liying Wang |Xijia Yang
Supporting Information As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
-
Jun 7, 2024 |
opg.optica.org | Song Gao |Shijing Guo |Jiaran Xiong |Dong Wang
Metamaterials, as novel materials, have electromagnetic behaviors that can be realized by rationally designing the unit structure. It plays an important role in the research of terahertz functional devices. Switchable terahertz devices are constructed by flexibly combining the excellent properties of graphene and vanadium dioxide (${{\rm VO}_2}$) with the application potential of terahertz technology.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →